Aktionsplan Piramal Pharma Limited
Über das Unternehmen Piramal Pharma Limited
Piramal Pharma Limited действует как фармацевтическая компания. Она продает портфель фармацевтических продуктов, а также предоставляет различные фармацевтические услуги, включая инъекции, HPAPI и т. д. Компания была зарегистрирована в 2020 году и базируется в Мумбаи, Индия. Piramal Pharma Limited действует как дочерняя компания Piramal Enterprises Limited.| ISIN | INE0DK501011 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | inr |
| Див.доход ао | 0.0704 |
| Дивиденд ао | 0.11 |
| Сайт | https://www.piramal.com/businesses/piramal-pharma/ |
| Цена ао | 219 |
| Preisänderung pro Tag: | -0.0959% (219) |
|---|---|
| Preisänderung pro Woche: | -1.13% (221.29) |
| Preisänderung pro Monat: | +3.83% (210.72) |
| Preisänderung über 3 Monate: | -14.98% (257.35) |
| Preisänderung über sechs Monate: | -1.93% (223.1) |
| Preisänderung pro Jahr: | +69.74% (128.9) |
| Preisänderung seit Jahresbeginn: | -14.98% (257.35) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| ETF | Aktie, % | Rentabilität für das Jahr, % | Dividenden, % |
|---|---|---|---|
| iShares MSCI India Small-Cap ETF | 0.37593 | 0.4625 | 0.96163 |
| SPDR S&P Emerging Markets Small Cap ETF | 0.14594 | 5.46 | 3.03583 |
| iShares MSCI Emerging Markets Small-Cap ETF | 0.12682 | 7.67 | 2.7853 |
| Dimensional Emerging Markets Value ETF | 0.08394 | 17.07 | 4.19508 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.04 | 9.39 | 3.09932 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.03273 | 15.96 | 3.34087 |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.0149 | 12.46 | 3.59676 |
| SPDR Portfolio Emerging Markets ETF | 0.0112 | 11.59 | 3.1879 |
iShares Core MSCI Total International Stock ETF
|
0.00784 | 6.4 | 3.25258 |
| Avantis Emerging Markets Equity ETF | 0.0078 | 8.77 | 3.60513 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00748 | 13.06 | 3.62488 |
| Avantis Responsible Emerging Markets Equity ETF | 0.00308 | 17.6 | 3.1719 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.07 | 10.18 | 3.15 |
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Ms. Nandini Ajay Piramal | Executive Chairperson | N/A | 1980 (45 Jahre) |
| Mr. Vivek Valsaraj | President, CFO & Executive Whole-Time Director | N/A | 1973 (52 Jahr) |
| Vinay Agarwal | Senior Vice President of Operations | N/A | 1964 (61 Jahr) |
| Sameer Penkar | Vice President of Marketing | N/A | |
| Prashanth M. S. | Vice President of Sales | N/A | 1973 (52 Jahr) |
| Mr. Vikram Duggal | Senior Vice President of Human Resources | N/A | 1975 (50 Jahre) |
| Mr. Debashish Chakravorty | Executive Vice President of India & UK Formulations | N/A | 1967 (58 Jahre) |
| Ms. Tanya Sanish | Company Secretary & Compliance Officer | N/A | |
| Mr. Peter Daniel DeYoung | CEO of Piramal Global Pharma & Director | N/A | 1978 (47 Jahre) |
| Mr. Gagan Borana | Head of Investor Relations & Sustainability |
Adresse: India, Mumbai, 507. Skyline Wealth Space - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.piramal.com/businesses/piramal-pharma/
Webseite: https://www.piramal.com/businesses/piramal-pharma/
